What is the market doing?
What the tape says about KNSA
Kiniksa Pharmaceuticals International, plc is +138% over the past year while the S&P 500 is +23%: 115 points ahead of the market.
+138%
1-year return · S&P 500 +23%
- vs 200-day average
- +58%
vs 200-day average · a clear uptrend
- RSI (14)
- 58
RSI (14) · neutral
- Below its 52-week high
- −2.6%
Below its 52-week high
Details›
- Last close2026-08-26
- $78.72
- 1 monthS&P 500 +3.7%
- +25%
- 1 yearS&P 500 +23%
- +138%
- 5 yearsS&P 500 +87%
- +385%
- vs 50-day average$64.38
- +22%
- 52-week high
- $80.83
- 52-week low
- $32.15
- Annualised volatility
- 49%
| Year | Return |
|---|---|
| 2026 (year to date) | +91% |
| 2025 | +109% |
| 2024 | +13% |
| 2023 | +17% |
| 2022 | +27% |
| 2021 | −33% |
| 2020 | +60% |
| 2019 | −61% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 4 of 8 | +0.59% |
| Feb | 8 | 6 of 8 | +4.7% |
| Mar | 8 | 3 of 8 | −4.2% |
| Apr | 8 | 3 of 8 | +2.8% |
| May | 8 | 5 of 8 | −0.81% |
| Jun | 9 | 7 of 9 | +6.6% |
| Jul | 9 | 6 of 9 | +9.1% |
| Aug | 9 | 4 of 9 | +2.8% |
| Sep | 8 | 4 of 8 | +1.1% |
| Oct | 8 | 1 of 8 | −11% |
| Nov | 8 | 7 of 8 | +19% |
| Dec | 8 | 4 of 8 | +2.9% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers - Specialty & Generic
Ranks #18 of 28 by Smart Score